Saos-2 cells

Saos-2 cells are a type of cancer cell line that is commonly used in biological research. They were originally derived from a primary osteosarcoma, a type of bone cancer, and are often used to study the biology of this disease.

History

Saos-2 cells were first established in the 1970s from an 11-year-old girl with osteosarcoma. The cells have been used in research for several decades and have contributed to many important discoveries in cancer biology.

Characteristics

Saos-2 cells are immortalized cells, meaning they can divide indefinitely in culture. They are also aneuploid, having an abnormal number of chromosomes. This is a common feature of cancer cells and is thought to contribute to their ability to grow and divide uncontrollably.

Saos-2 cells are epithelial in nature, meaning they resemble the type of cells that line the body's surfaces and cavities. They grow in a monolayer, or single layer, in culture.

Use in Research

Saos-2 cells are used in a wide range of research applications. They are often used to study the biology of osteosarcoma, including the genetic changes that drive this disease and the pathways that are involved in its growth and progression.

Saos-2 cells are also used in drug discovery and development. Researchers can test potential new drugs on these cells to see if they have any effect on their growth or survival. This can help to identify promising new treatments for osteosarcoma.

Limitations

While Saos-2 cells are a valuable tool in cancer research, they do have some limitations. Like all cell lines, they do not perfectly represent the complexity of human tumors. They lack the diversity of cell types found in actual tumors, and they do not interact with the immune system or other parts of the body in the same way that tumors do. Therefore, while they can provide important insights, their findings must be validated in other models and in clinical trials.

This article is a medical stub. You can help WikiMD by expanding it!
Most recent articles Ongoing trials	Wikipedia